Caxton Associates (New York)’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23,948
Closed -$1.15M 477
2023
Q4
$1.15M Buy
+23,948
New +$1.14M 0.06% 206
2022
Q1
Sell
-6,267
Closed -$296K 551
2021
Q4
$296K Sell
6,267
-19,837
-76% -$903K 0.03% 413
2021
Q3
$1.1M Buy
+26,104
New +$1.13M 0.12% 88

Other funds holding CTVA

Caxton Associates (New York)'s CTVA Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Corteva (CTVA) in Q1 2024, closing a stake of 23,948 shares — an estimated $1.15M sold.

Caxton Associates (New York) first reported a position in CTVA in Q3 2021 and held it in 3 quarters. The position peaked at $1.15M in Q4 2023. 1,260 funds tracked by Wall St. Rank hold CTVA as of Q1 2024.

  • Caxton Associates (New York) reported no remaining Corteva position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 23,948 Corteva shares in Q1 2024, an estimated $1.15M.
  • Caxton Associates (New York) first reported a position in Corteva in Q3 2021 and held it in 3 quarters.
  • Caxton Associates (New York)'s Corteva position peaked at $1.15M in Q4 2023.
  • 1,260 funds tracked by Wall St. Rank held Corteva as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.